American Oriental Bioengineering, Inc.

AOBI · OTC
Analyze with AI
12/31/2012
12/31/2011
12/31/2010
12/31/2009
Operating Activities
Net Income-$60-$68$16$41
Dep. & Amort.$12$12$13$12
Deferred Tax$1-$6-$0-$1
Stock-Based Comp.$3$3$3$3
Change in WC-$7$12-$25-$29
Other Non-Cash$5$76$1-$1
Operating Cash Flow-$46$30$8$25
Investing Activities
PP&E Inv.-$26-$50-$6-$5
Net Acquisitions$18$6$0$1
Inv. Purchases-$5-$28-$0-$0
Inv. Sales/Matur.-$7$13$0$6
Other Inv. Act.$35-$13-$0-$1
Investing Cash Flow$15-$72-$6$1
Financing Activities
Debt Repay.-$8-$4-$7-$3
Stock Issued$0$0$0$0
Stock Repurch.-$1-$1$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.-$6$0$3$0
Financing Cash Flow-$15-$4-$4-$3
Forex Effect$1$4$5$0
Net Chg. in Cash-$46-$42$3$24
Supplemental Information
Beg. Cash$53$95$91$71
End Cash$7$53$95$94
Free Cash Flow-$73-$20$2$20